Edwards Lifesciences Share Price Undervalued by 12.6%: DCF Analysis

Edwards Lifesciences' recent share price of $78.10 shows a 7-day return of -4.2%, a 30-day return of -9.0%, and a year-to-date return of -8.5%. The company's valuation score is 2 out of 6, indicating undervaluation. The discounted cash flow model estimates an intrinsic value of $89.38 per share, representing a 12.6% discount compared to the current share price.